Nephrology News

Researchers found that patients who participated in an obesity management program and were taking weight-loss medication reported drinking less alcohol.

Exposure to per- and polyfluoroalkyl substances may be linked to worse kidney function by reduced short-chain fatty acid-producing bacteria and anti-inflammatory metabolites, according to a proof-of-concept analysis.

GLP-1 receptor agonists improved clinical outcomes related to kidney and heart health while lowering mortality rates for individuals with diabetes, chronic kidney disease or preexisting cardiovascular disease with overweight or obesity.

Nitrofurantoin and cranberry products may reduce recurrent UTI episodes in children when used as prophylaxis, according to the results of a systematic review and meta-analysis published in Pediatrics.

Unintended pregnancy after kidney transplantation was not linked to perinatal acute allograft rejection but was associated with mycophenolate exposure and allograft loss at 2 years postpartum, according to data published in O&G Open.

SAN DIEGO — Nearly 75% of kidney transplant recipients at a U.S. hospital who survived at least 1 year did not see a primary care provider in the years following the procedure, according to study data.

Early treatment with mycophenolate mofetil can reduce subsequent risks for severe flares and lupus nephritis in newly diagnosed systemic lupus erythematosus, according to data published in JAMA Network Open.

Prescriptions for GLP-1 receptor agonists and SGLT2 inhibitors for patients with type 1 diabetes rose between 2010 and 2023 despite not being approved for that population, according to a research letter published in JAMA.

The 19th annual Cardiometabolic Health Congress will be held at the Boston Park Plaza and will feature the latest science in the areas of cardio-renal, obesity, diabetes and dyslipidemia, atherosclerosis, thrombosis and more.